Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Congresswoman Giffords Continues to Improve
Rep. Gabrielle Giffords continues her steady progress as she
recovers from a gunshot to the head suffered during a Jan. 8
assassination attempt in Phoenix, a family friend says.
Tilman Fertitta told the
Associated Press that Giffords laughs at jokes and recognizes
"There's lots of excitement as she continues to speak more and improve," he said. "She's in a great mood and working hard."
Giffords is undergoing intensive rehabilitation at TIRR Memorial
Hermann Hospital in Houston. She is in therapy from morning till
night and sees her husband Mark Kelly every day, Fertitta told the
Kelly is an astronaut who is training for the next space shuttle
launch in April. Doctors say it's too early to say whether Giffords
will be able to attend the launch.
FDA Warns Pregnant Women About Asthma Drug
Certain uses of the asthma drug terbutaline to treat preterm
labor in pregnant women can lead to heart problems and death, the
U.S. Food and Drug Administration warned Thursday.
"Women should be aware that serious and sometimes fatal side effects have been reported after prolonged use of terbutaline in pregnant women," Dr. Scott Munroe, director of the FDA's Division of Reproductive and Urologic Products, said in an agency news release.
The drug is approved to prevent and treat narrowing of the
airways caused by asthma, bronchitis and emphysema, but is also
used for unapproved (off-label) obstetric purposes, including
treating preterm labor.
The FDA said the drug's labeling will now have to carry a
warning that "terbutaline administered by injection or through an
infusion pump should not be used in pregnant women for prevention
or prolonged (longer than 48 to 72 hours) treatment of preterm
labor. In addition, oral terbutaline should not be used for
prevention or treatment of preterm labor."
Elephant Sanctuary Workers Caught TB From Pachyderm: CDC
An elephant named Liz was the cause of a tuberculosis outbreak
that affected eight workers at a Tennessee elephant sanctuary in
2009, according to the U.S. Centers for Disease Control and
Agency investigators said Liz had been diagnosed with the
disease and TB bacteria could have spread through the air when the
elephant sneezed, or through pressure washing or dust from cleaning
the barn where Liz was kept, the
Associated Press reported.
The eight workers received treatment but are not sick or
hazardous to other people, according to officials at the sanctuary,
located about 85 miles southwest of Nashville.
Liz received treatment and is still alive, the
Caramel Coloring in Colas Poses Cancer Risk: Consumer Group
Caramel coloring used in colas and some other drinks and foods
may cause cancer and should be banned, says the Center for Science
in the Public Interest.
"We're asking the FDA to ban the use of caramel coloring that's used in colas and certain other soft drinks and a variety of other foods," said Michael Jacobson, the consumer group's executive director, ABC News reported.
Several years ago, a U.S. government agency tested a contaminant
in the coloring and found that it caused cancer in mice and
possibly rats, he said.
The soft drink industry strongly objected to the claim,
ABC News reported.
"CSPI's statement irresponsibly insinuates that the caramel used in our beverages is unsafe and maliciously raises cancer concerns among consumers," the Coca-Cola Company said in a statement. "This does a disservice to the very public for which CSPI purports to serve. In fact studies show that the caramel we use does not cause cancer."
FDA Expands Eligibility for Weight Loss Surgery Device
New rules that make more Americans eligible for weight loss
surgery were approved Wednesday by the U.S. Food and Drug
Previously, the use of Allergan's Lap-Band stomach restricting
device was limited to people with a body mass index (BMI) of at
least 40 if they had no obesity-related health problems such as
diabetes and high blood pressure, and a BMI of at least 35 if they
did have health issues.
Under the new rules, the device can be used on people with a BMI
of at least 30 who have an obesity-related health condition. A BMI
of at least 40 remains the threshold for otherwise healthy people,
The New York Times reported.
"In order to target this therapy to patients who will benefit the most, the approved indication is limited to patients at the highest risk of obesity-related complications," said FDA spokeswoman Karen Riley.
Allergan estimated the changes will more than double the number
of Americans eligible for the weight loss surgery (26 million
instead of 15 to 18 million), the
Anti-Stress Chemical Triggers Hair Growth in Mice
Mice re-grew hair after being given a chemical compound that
blocks a stress-related hormone, U.S. researchers say.
Their accidental discovery occurred when they gave astressin-B
to mice that were genetically engineered to produce too much of the
stress hormone corticotrophin-releasing factor (CRF). The chronic
stress experienced by the mice causes them to lose the hair on
Agence France-Presse reported.
Within a few months of receiving astressin-B, the mice had
regained all their hair, said the researchers at the University of
California, Los Angeles and the Veterans Administration.
"This could open up new venues to treat hair loss in humans through the modulation of the stress hormone receptors, particularly hair loss related to chronic stress and aging," said Million Mulugeta, of the David Geffen School of Medicine at UCLA, AFP reported.
The study appears in the online journal
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.